Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial.

by David A Wohl, Laveeza Bhatti, Catherine B Small, Howard Edelstein, Henry H Zhao, David A Margolis, Edwin DeJesus, Winkler G Weinberg, Lisa L Ross, Mark S Shaefer
Published 2014-01-01